检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:刘亚妮[1] 刘金梅[1] 马林[1] 吕永宁[1] 李忠芳[1] 师少军[1]
机构地区:[1]华中科技大学同济医学院附属协和医院药剂科,武汉430022
出 处:《中国药学杂志》2012年第2期132-136,共5页Chinese Pharmaceutical Journal
摘 要:目的研究中国健康受试者静脉注射头孢替坦二钠后的药动学特征。方法 30名健康受试者随机分为3组,男、女各半,分别静脉滴注头孢替坦二钠0.5、1.0、2.0 g,进行低、中、高单剂量药动学研究。1.0 g剂量组并进行多剂量药动学研究。采用HPLC-UV测定血浆中头孢替坦二钠的浓度。应用DAS2.1.1软件计算药动学参数,并进行统计分析。结果 30名健康受试者分别单次静脉滴注头孢替坦二钠0.5,1.0,2.0 g的主要药动学参数如下:ρmax为(68.03±15.95)、(110.77±17.67)、(225.34±19.63)mg.L-1;AUC0-15为(242.88±56.60)、(415.22±54.24)、(856.18±82.72)mg.h.L-1;t1/2为(3.67±0.48)、(3.69±0.40)、(3.53±0.26)h。多次给药的主要药动学参数如下:ρmax为(123.60±15.74)mg.L-1;AUC0-15为(444.38±62.78)mg.h.L-1;AUCSS为(426.87±59.36)mg.h.L-1;t1/2为(3.29±0.36)h;ρav为(35.57±4.95)mg.L-1。结论注射用头孢替坦二钠单剂量静脉滴注后在0.5~2.0 g内呈线性动力学特征;连续给药后在体内无蓄积;性别对注射用头孢替坦二钠的体内药动学无差异。OBJECTIVE To study the pharmacokinetics of cefotetan disodium for injection in Chinese healthy volunteers. METHODS Thirty healthy volunteers were randomly divided into 3 groups with 5 males and 5 females in each group. The volunteers in each group were administered a single dose of eefotetan disodium of 0. 5, 1.0, or 2. 0 g, respectively. Those who got dose of 1.0 g were administered twice daily for 7 d. The concentrations of eefotetan disodium in plasma were determined by HPLC while the pharma- eokinetic parameters were calculated by DAS software. RESULTS The main pharmacokinetic parameters of cefotetan disodium after single-dose intravenous administration were as follows: ρmax(68. 03 ± 15. 95), (110. 77 ± 17. 67), (225. 34 ± 19. 63) mg· L^-1; AUC0-15(242.88 ±56.60), (415.22 ±54.24), (856.18 ±82.72) mg · h · L ^-1; t1/2 (3.67 ± 0.48), (3.69 ±0.40), ( 3.53 ± 0. 26 ) h, respectively. The main pharmacokinetic parameters of cefotetan disodium after multiple-dose administration were as follows : ρmax ( 123.60 ± 15.74 ) mg· L ^-1 ; AUC0-15 ( 444. 38 ± 62. 78 ) mg·h · L^- 1 ; AUCss ( 426. 87 ± 59. 36 ) mg · h· L^- 1 ; t1/2 (3.29 ±0. 36)h; ρav(35.57 ±4.95) mg · L^-1 , respectively. CONCLUSION Cefotetan disodium for injection displays linear phar- macokinetics in the dose range of 0. 5 to 2. 0 g after single intravenous dosing. There is no significant accumulation after repeated dosing. There is no significant difference in the pharmaeokinetic parameters between female and male subjects.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.15